Is Cardiac Magnetic Resonance Imaging Useful in Chemotherapy Induced Cardiotoxicity
Dr. Baliga's 'Got Knowledge Doc?' PODKASTS
Release Date: 10/08/2022
Dr. Baliga's 'Got Knowledge Doc?' PODKASTS
info_outlineDr. Baliga's 'Got Knowledge Doc?' PODKASTS
π§ Dr RR Baliga's Got Knowledge Doc' PODKASTS for Physicians: on 'Hypertension in the Cardio-Oncology Clinic' . Not Medical Advice or Opinion
info_outlineDr. Baliga's 'Got Knowledge Doc?' PODKASTS
Door-to-Guideline Directed Medical Therapy Time & Door to Max Dose GDMT Time for Heart Failure
info_outlineDr. Baliga's 'Got Knowledge Doc?' PODKASTS
π§Β Transthyretin (TTR) Amyloid: "Hot-off-the-Press Dr RR Baliga "Got Knowledge Doc" PodKast"
info_outlineDr. Baliga's 'Got Knowledge Doc?' PODKASTS
Dr RR Baliga's Internal Medicine Podcast for Physicians: MUST KNOW FACTs about Asthma
info_outlineDr. Baliga's 'Got Knowledge Doc?' PODKASTS
from the chapter
info_outlineDr. Baliga's 'Got Knowledge Doc?' PODKASTS
info_outline
Dr. Baliga's 'Got Knowledge Doc?' PODKASTS
Dr RR Baliga's Internal Medicine Podcasts for Physicians: MUST KNOW FACTs about Statistics.
info_outlineDr. Baliga's 'Got Knowledge Doc?' PODKASTS
Head & Neck Malignancies -3 (Summary)
info_outlineDr. Baliga's 'Got Knowledge Doc?' PODKASTS
Head & Neck Malignancies -2
info_outlineDr RR Baliga's 'Got Knowledge Doc?' PodKasts for Physicians| Is Cardiac Magnetic Resonance Imaging Useful in Chemotherapy Induced Cardiotoxicity
- Cardiovascular magnetic resonance in immune checkpoint inhibitor-associated myocarditis European Heart Journal, Volume 41, Issue 18, 7 May 2020, Pages 1733β1743,
- Immune checkpoint inhibitor cardiotoxicity: what can we learn from real life data on CMR as a diagnostic tool? European Heart Journal, Volume 41, Issue 18, 7 May 2020, Pages 1744β1746
- Can Quantitative CMR Tissue Characterization Adequately Identify Cardiotoxicity During Chemotherapy? Impact of Temporal and Observer Variability. JACC Cardiovasc Imaging 2020;13:951-962.